世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oncology Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4604 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・腫瘍バイオマーカーの種類別市場規模と予測2016-2027（血液がん、固形腫瘍、その他） ・腫瘍バイオマーカーの用途別市場規模と予測2016-2027（診断、創薬・開発、予後、リスクアセスメント、その他） ・腫瘍バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍バイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Bristol-Myers Squibb、Eli Lilly and Company、F.Hoffmann-La Roche Ltd.、Genomic Health、GlaxoSmithKline plc、Novartis AG、Merck & Co.、Pfizer、Qiagen N.V.） ・結論

A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.

Market Analysis and Insights: Global Oncology Biomarker Market
The global Oncology Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Biomarker market.

Global Oncology Biomarker Scope and Market Size
Oncology Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others

Segment by Application
Diagnostics
Drug Discovery And Development
Prognostics
Risk Assessment
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Pfizer
Qiagen N.V.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Prostate Cancer
1.2.6 Stomach Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Oncology Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery And Development
1.3.4 Prognostics
1.3.5 Risk Assessment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Biomarker Market Perspective (2016-2027)
2.2 Oncology Biomarker Growth Trends by Regions
2.2.1 Oncology Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Biomarker Industry Dynamic
2.3.1 Oncology Biomarker Market Trends
2.3.2 Oncology Biomarker Market Drivers
2.3.3 Oncology Biomarker Market Challenges
2.3.4 Oncology Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Biomarker Players by Revenue
3.1.1 Global Top Oncology Biomarker Players by Revenue (2016-2021)
3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Biomarker Revenue
3.4 Global Oncology Biomarker Market Concentration Ratio
3.4.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2020
3.5 Oncology Biomarker Key Players Head office and Area Served
3.6 Key Players Oncology Biomarker Product Solution and Service
3.7 Date of Enter into Oncology Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Biomarker Breakdown Data by Type
4.1 Global Oncology Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Oncology Biomarker Forecasted Market Size by Type (2022-2027)

5 Oncology Biomarker Breakdown Data by Application
5.1 Global Oncology Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Oncology Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oncology Biomarker Market Size (2016-2027)
6.2 North America Oncology Biomarker Market Size by Type
6.2.1 North America Oncology Biomarker Market Size by Type (2016-2021)
6.2.2 North America Oncology Biomarker Market Size by Type (2022-2027)
6.2.3 North America Oncology Biomarker Market Size by Type (2016-2027)
6.3 North America Oncology Biomarker Market Size by Application
6.3.1 North America Oncology Biomarker Market Size by Application (2016-2021)
6.3.2 North America Oncology Biomarker Market Size by Application (2022-2027)
6.3.3 North America Oncology Biomarker Market Size by Application (2016-2027)
6.4 North America Oncology Biomarker Market Size by Country
6.4.1 North America Oncology Biomarker Market Size by Country (2016-2021)
6.4.2 North America Oncology Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oncology Biomarker Market Size (2016-2027)
7.2 Europe Oncology Biomarker Market Size by Type
7.2.1 Europe Oncology Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Oncology Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Oncology Biomarker Market Size by Type (2016-2027)
7.3 Europe Oncology Biomarker Market Size by Application
7.3.1 Europe Oncology Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Oncology Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Oncology Biomarker Market Size by Application (2016-2027)
7.4 Europe Oncology Biomarker Market Size by Country
7.4.1 Europe Oncology Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Oncology Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oncology Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Oncology Biomarker Market Size by Type
8.2.1 Asia-Pacific Oncology Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Biomarker Market Size by Application
8.3.1 Asia-Pacific Oncology Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Biomarker Market Size by Region
8.4.1 Asia-Pacific Oncology Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oncology Biomarker Market Size (2016-2027)
9.2 Latin America Oncology Biomarker Market Size by Type
9.2.1 Latin America Oncology Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Biomarker Market Size by Type (2016-2027)
9.3 Latin America Oncology Biomarker Market Size by Application
9.3.1 Latin America Oncology Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Biomarker Market Size by Application (2016-2027)
9.4 Latin America Oncology Biomarker Market Size by Country
9.4.1 Latin America Oncology Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oncology Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Oncology Biomarker Market Size by Type
10.2.1 Middle East & Africa Oncology Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Biomarker Market Size by Application
10.3.1 Middle East & Africa Oncology Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Biomarker Market Size by Country
10.4.1 Middle East & Africa Oncology Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Biomarker Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
11.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Oncology Biomarker Introduction
11.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 F.Hoffmann-La Roche Ltd.
11.4.1 F.Hoffmann-La Roche Ltd. Company Details
11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
11.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2016-2021)
11.4.5 F.Hoffmann-La Roche Ltd. Recent Development
11.5 Genomic Health
11.5.1 Genomic Health Company Details
11.5.2 Genomic Health Business Overview
11.5.3 Genomic Health Oncology Biomarker Introduction
11.5.4 Genomic Health Revenue in Oncology Biomarker Business (2016-2021)
11.5.5 Genomic Health Recent Development
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
11.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2016-2021)
11.6.5 GlaxoSmithKline plc Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Oncology Biomarker Introduction
11.7.4 Novartis AG Revenue in Oncology Biomarker Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Oncology Biomarker Introduction
11.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2016-2021)
11.8.5 Merck & Co. Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oncology Biomarker Introduction
11.9.4 Pfizer Revenue in Oncology Biomarker Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Qiagen N.V.
11.10.1 Qiagen N.V. Company Details
11.10.2 Qiagen N.V. Business Overview
11.10.3 Qiagen N.V. Oncology Biomarker Introduction
11.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2016-2021)
11.10.5 Qiagen N.V. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Breast Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Prostate Cancer
Table 6. Key Players of Stomach Cancer
Table 7. Key Players of Others
Table 8. Global Oncology Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oncology Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Oncology Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Oncology Biomarker Market Share by Regions (2016-2021)
Table 12. Global Oncology Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Oncology Biomarker Market Share by Regions (2022-2027)
Table 14. Oncology Biomarker Market Trends
Table 15. Oncology Biomarker Market Drivers
Table 16. Oncology Biomarker Market Challenges
Table 17. Oncology Biomarker Market Restraints
Table 18. Global Oncology Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Oncology Biomarker Market Share by Players (2016-2021)
Table 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2020)
Table 21. Ranking of Global Top Oncology Biomarker Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Oncology Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oncology Biomarker Product Solution and Service
Table 25. Date of Enter into Oncology Biomarker Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Oncology Biomarker Revenue Market Share by Type (2016-2021)
Table 29. Global Oncology Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Oncology Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Oncology Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Oncology Biomarker Revenue Market Share by Application (2016-2021)
Table 33. Global Oncology Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Oncology Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Oncology Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Oncology Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oncology Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Oncology Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Oncology Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Oncology Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Oncology Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Oncology Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Oncology Biomarker Product
Table 68. Abbott Laboratories Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 69. Abbott Laboratories Recent Development
Table 70. Bristol-Myers Squibb Company Details
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb Oncology Biomarker Product
Table 73. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Eli Lilly and Company Company Details
Table 76. Eli Lilly and Company Business Overview
Table 77. Eli Lilly and Company Oncology Biomarker Product
Table 78. Eli Lilly and Company Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 79. Eli Lilly and Company Recent Development
Table 80. F.Hoffmann-La Roche Ltd. Company Details
Table 81. F.Hoffmann-La Roche Ltd. Business Overview
Table 82. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product
Table 83. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 84. F.Hoffmann-La Roche Ltd. Recent Development
Table 85. Genomic Health Company Details
Table 86. Genomic Health Business Overview
Table 87. Genomic Health Oncology Biomarker Product
Table 88. Genomic Health Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 89. Genomic Health Recent Development
Table 90. GlaxoSmithKline plc Company Details
Table 91. GlaxoSmithKline plc Business Overview
Table 92. GlaxoSmithKline plc Oncology Biomarker Product
Table 93. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 94. GlaxoSmithKline plc Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Oncology Biomarker Product
Table 98. Novartis AG Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 99. Novartis AG Recent Development
Table 100. Merck & Co. Company Details
Table 101. Merck & Co. Business Overview
Table 102. Merck & Co. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 103. Merck & Co. Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Oncology Biomarker Product
Table 107. Pfizer Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 108. Pfizer Recent Development
Table 109. Qiagen N.V. Company Details
Table 110. Qiagen N.V. Business Overview
Table 111. Qiagen N.V. Oncology Biomarker Product
Table 112. Qiagen N.V. Revenue in Oncology Biomarker Business (2016-2021) & (US$ Million)
Table 113. Qiagen N.V. Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Lung Cancer Features
Figure 3. Breast Cancer Features
Figure 4. Colorectal Cancer Features
Figure 5. Prostate Cancer Features
Figure 6. Stomach Cancer Features
Figure 7. Others Features
Figure 8. Global Oncology Biomarker Market Share by Application: 2020 VS 2027
Figure 9. Diagnostics Case Studies
Figure 10. Drug Discovery And Development Case Studies
Figure 11. Prognostics Case Studies
Figure 12. Risk Assessment Case Studies
Figure 13. Others Case Studies
Figure 14. Oncology Biomarker Report Years Considered
Figure 15. Global Oncology Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Oncology Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Oncology Biomarker Market Share by Regions: 2020 VS 2027
Figure 18. Global Oncology Biomarker Market Share by Regions (2022-2027)
Figure 19. Global Oncology Biomarker Market Share by Players in 2020
Figure 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2020
Figure 22. Global Oncology Biomarker Revenue Market Share by Type (2016-2021)
Figure 23. Global Oncology Biomarker Revenue Market Share by Type (2022-2027)
Figure 24. North America Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Oncology Biomarker Market Share by Type (2016-2027)
Figure 26. North America Oncology Biomarker Market Share by Application (2016-2027)
Figure 27. North America Oncology Biomarker Market Share by Country (2016-2027)
Figure 28. United States Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Oncology Biomarker Market Share by Type (2016-2027)
Figure 32. Europe Oncology Biomarker Market Share by Application (2016-2027)
Figure 33. Europe Oncology Biomarker Market Share by Country (2016-2027)
Figure 34. Germany Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Oncology Biomarker Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Oncology Biomarker Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Oncology Biomarker Market Share by Region (2016-2027)
Figure 44. China Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Oncology Biomarker Market Share by Type (2016-2027)
Figure 52. Latin America Oncology Biomarker Market Share by Application (2016-2027)
Figure 53. Latin America Oncology Biomarker Market Share by Country (2016-2027)
Figure 54. Mexico Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Oncology Biomarker Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Oncology Biomarker Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Oncology Biomarker Market Share by Country (2016-2027)
Figure 60. Turkey Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Oncology Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 66. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 67. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 68. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 70. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 72. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---